by AFP | Feb 5, 2020 | News, Pharmaceutical
More than 75,000 people—ten times the official tally of confirmed cases—have been infected with the coronavirus in Wuhan, ground zero of a global health emergency, according to research published Friday. “We estimate that 75,815 individuals have been infected in...
by Se Young Lee, Hallie Gu | Jan 22, 2020 | Hospitals, News, Pharmaceutical
BEIJING (Reuters) – China reported four more cases of pneumonia believed to be caused by a new coronavirus strain, causing rising concern globally that a disease health officials do not yet fully understand could spread during a key holiday period. The new...
by Carl O'Donnell in New York and Tamara Mathias in Bengaluru; Editing by Tomasz Janowski, Michele Gershberg and Mark Potter | Dec 6, 2019 | Inspiration, News, Pharmaceutical
Reuters – Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018, according to a Reuters analysis, in a drive to better control production of the world’s priciest medicines. FILE...
by Society for Healthcare Epidemiology of America | Nov 5, 2019 | News, Pharmaceutical
Overuse of antibiotics in healthcare contributes to the development of antibiotic-resistant bacteria, resulting in 2 million infections and 100,000 deaths in the U.S. each year, but research is lacking to inform antibiotic stewardship programs aimed at reining in...
by John Miller | Sep 2, 2019 | Pharmaceutical
FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel, Switzerland, March 29, 2018. REUTERS/Arnd Wiegmann/File Photo ZURICH (Reuters) – Swiss drugmaker Novartis on Friday stepped up its challenge to Roche’s multiple...
by Manojna Maddipatla | Aug 21, 2019 | Pharmaceutical
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland (Reuters) – Roche Holding AG has priced at about $204,560 a year its personalized cancer treatment, Rozlytrek, that targets tumors with specific genetic mutations,...
